A Phase 4 interventional study of Dermabond- liquid skin adhesive in Cesarean Section Wound, sponsored by Meir Medical Center. Status unknown at 1 site in Israel. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2010-12-16.
Sponsored by Meir Medical Center · Phase 4, Interventional, and Treatment
Two of the more frequently used options for skin closure following a cesarean delivery include staples or sutures (stitches). Another method of closure is Dermabond- liquid skin adhesive. This method of closure is used less frequently than either staples or sutures.
Few studies have been done regarding whether Dermabond is preferable or affect the outcome of a cesarean section surgery. The aim of our study is to find weather Dermabond haas better result for the closure of cesarean section wounds.
Meir Medical Center is the lead sponsor of 400 studies on the registry; 25 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Woman over 18 year Woman having elective caesarean section
Exclusion Criteria:
Age under 18 Woman having an emergency caesarean section
Procedure: Dermabond- liquid skin adhesive
Dermabond- liquid skin adhesive
Cosmetic objective evaluation of the scar
Time frame: 6 weeks postoperatively
The difference in pain between the two type of closure
Time frame: 1 and 4 days postoperatively
The difference in patient satisfaction with the scar result
Time frame: 6 weeks postoperatively
This study is status unknown, as verified in Oct 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.